Lynley Durrett
Atlanta, GANPI 1073501169
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $815 and has fallen 59.8% since, to $328 in 2025.
Across 158 payments — averaging $21.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$556
- AbbVie$512
- Hologic Sales And Service, LLC$373
- Mayne Pharma Commercial LLC$206
- Therapeuticsmd, Inc.$191
- Avanos Medical$166
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,24496%
- Education$1334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 25 | $556 |
| AbbVie | 25 | $512 |
| Hologic Sales And Service, LLC | 13 | $373 |
| Mayne Pharma Commercial LLC | 11 | $206 |
| Therapeuticsmd, Inc. | 11 | $191 |
| Avanos Medical | 4 | $166 |
| Shield Therapeutics Inc | 7 | $160 |
| Millicent US Inc | 6 | $122 |
| Pfizer | 7 | $120 |
| Bayer | 6 | $116 |
| Medtronic | 4 | $111 |
| Scynexis, Inc. | 6 | $97 |
| Smith+Nephew | 2 | $84 |
| Boston Scientific | 3 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Merck | 3 | $45 |
| Myovant Sciences Inc. | 2 | $43 |
| Stryker | 2 | $43 |
| Avion Pharmaceuticals | 3 | $41 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Acessa Health Inc.(2 entities) | 2 | $29 |
| Mycovia Pharmaceuticals, Inc. | 1 | $28 |
| Axonics, Inc. | 1 | $26 |
| Baxter Healthcare | 1 | $24 |
| Exact Sciences | 1 | $23 |
| Duchesnay USA Incorporated | 1 | $20 |
| Coopersurgical, Inc. | 1 | $18 |
| Lupin Inc. | 1 | $18 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Mimedx Group, Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Dysis Medical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 19 | $3,208 |
| Estradiol (Twice Weekly)Estradiol | 16 | $2,238 |
| ProgesteroneProgesterone, Micronized | 12 | $671 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.